COVID-19

With increased infectivity of Omicron, the CDC has updated the guidance on the best mask types to use.

Spending may have reached $130 million despite a lack of evidence that ivermectin effectively treats COVID-19.

COVID-19 updates and news to know as of January 17, 2022.

Employee mandate would have impacted 84 million workers. Healthcare mandate affects every facility that receives federal funding.

A global study examines how often severe outcomes occur within 14 days of a positive COVID-19 test occurring in an emergency department (ED).

But protection against hospitalization and death remain strong.

Since the COVID-19 vaccinations have been approved, there have been numerous trials that have all concluded that vaccines are safe for people with HIV.

COVID-19 updates and news to know as of January 11, 2022.

Do no harm, even though your patient might.

As the need for rapid tests increase, the nation's largest non-profit patient safety organization evaluated seven COVID-19 rapid tests and found serious gaps in their usability.

The Centers for Disease and Control and Prevention (CDC) has given their support for giving a COVID-19 booster to children aged 12 to 15 years.

As trusted source of information for parents, pharmacists are a key part of the plan to distribute the COVID-19 vaccine to newly eligible children.

How to educate patients about the safety of receiving the influenza and COVID-19 vaccines at the same time.

The US Food and Drug Administration (FDA) made multiple changes to the emergency use authorization for the Pfizer/BioNTech vaccine.

According to researchers, the Omicron variant developed one of its mutations by picking up a piece of genetic material from the common cold.

COVID-19 updates and news to know as of January 3, 2022.

Burnout, COVID-19 vaccines, and increased demands have come together to create the perfect storm of labor shortages within the industry.

The company says a third dose of their COVID-19 vaccine is effective against the latest variant of the disease.

CDC data shown to overstate US vaccination rates; school-based cognitive behavioral therapy for overwhelmed children; Moderna to develop Omicron-specific COVID-19 booster dose.

A research team in Hong Kong reported preliminary results from experiments that show the omicron variants multiplies 70 times faster inside respiratory than the delta variant.

New study shows opportunity exists to make healthcare more durable to further long-term gains in preparedness for emergencies like COVID-19.

In the space of 2 days, the FDA approved at-home oral treatments for patients with mild-to-moderate COVID-19, drug that were months in development. Today, it was Merck and Ridgeback Biotherapeutics’ turn.

The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.

The Johnson & Johnson vaccine is staying on the market, but the preference for the Pfizer and Moderna mRNA vaccines stems from concerns about the rare but real risk of blood clots from the J&J vaccine.

The company says a third dose of their COVID-19 vaccine is effective against the latest variant of the disease.